Arkolith/Insider Trading/PHAT/Form 4

Parikh Asit

DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed May 21, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)18K$4.95$87K52K
May 19, 2026Grant(A)24K—$035K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Disposed to issuer(D)18K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-234891) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML